JPMorgan Chase & Co’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43 | Hold |
143
| – | – | ﹤0.01% | 6018 |
|
|
2025
Q1 | $41 | Hold |
143
| – | – | ﹤0.01% | 6137 |
|
|
2024
Q4 | $84 | Sell |
143
-6,477
| -98% | -$3.81K | ﹤0.01% | 5981 |
|
|
2024
Q3 | $2.95K | Buy |
6,620
+6,477
| +4,529% | +$2.89K | ﹤0.01% | 5502 |
|
|
2024
Q2 | $379 | Sell |
143
-7,394
| -98% | -$19.6K | ﹤0.01% | 5690 |
|
|
2024
Q1 | $20.7K | Buy |
7,537
+7,394
| +5,171% | +$20.3K | ﹤0.01% | 5227 |
|
|
2023
Q4 | $347 | Sell |
143
-850
| -86% | -$2.06K | ﹤0.01% | 5937 |
|
|
2023
Q3 | $2.01K | Sell |
993
-40
| -4% | -$81 | ﹤0.01% | 5588 |
|
|
2023
Q2 | $3.05K | Sell |
1,033
-26,005
| -96% | -$76.7K | ﹤0.01% | 5371 |
|
|
2023
Q1 | $67K | Buy |
27,038
+6,542
| +32% | +$16.2K | ﹤0.01% | 4803 |
|
|
2022
Q4 | $65K | Sell |
20,496
-548
| -3% | -$1.74K | ﹤0.01% | 4640 |
|
|
2022
Q3 | $62K | Buy |
21,044
+1,305
| +7% | +$3.85K | ﹤0.01% | 4630 |
|
|
2022
Q2 | $60K | Buy |
19,739
+239
| +1% | +$726 | ﹤0.01% | 4800 |
|
|
2022
Q1 | $263K | Buy |
19,500
+3,869
| +25% | +$52.2K | ﹤0.01% | 4304 |
|
|
2021
Q4 | $204K | Sell |
15,631
-77,864
| -83% | -$1.02M | ﹤0.01% | 4523 |
|
|
2021
Q3 | $877K | Buy |
93,495
+81,104
| +655% | +$761K | ﹤0.01% | 3689 |
|
|
2021
Q2 | $127K | Buy |
12,391
+163
| +1% | +$1.67K | ﹤0.01% | 4685 |
|
|
2021
Q1 | $225K | Sell |
12,228
-19,077
| -61% | -$351K | ﹤0.01% | 4412 |
|
|
2020
Q4 | $1.07M | Buy |
+31,305
| New | +$1.07M | ﹤0.01% | 3340 |
|